- Home
- KRMD vs SEER Comparison
KRMD vs SEER Comparison
Compare KRMD & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- SEER
- Stock Information
- Founded
- KRMD 1980
- SEER 2017
- Country
- KRMD United States
- SEER United States
- Employees
- KRMD N/A
- SEER 134
- Industry
- KRMD Medical/Dental Instruments
- SEER Medicinal Chemicals and Botanical Products
- Sector
- KRMD Health Care
- SEER Health Care
- Exchange
- KRMD Nasdaq
- SEER Nasdaq
- Market Cap
- KRMD 126.9M
- SEER 121.8M
- IPO Year
- KRMD N/A
- SEER 2020
- Fundamental
- Price
- KRMD $3.15
- SEER $1.84
- Analyst Decision
- KRMD Strong Buy
- SEER Hold
- Analyst Count
- KRMD 4
- SEER 1
- Target Price
- KRMD $4.63
- SEER $3.00
- AVG Volume (30 Days)
- KRMD 113.3K
- SEER 174.6K
- Earning Date
- KRMD 05-07-2025
- SEER 05-13-2025
- Dividend Yield
- KRMD N/A
- SEER N/A
- EPS Growth
- KRMD N/A
- SEER N/A
- EPS
- KRMD N/A
- SEER N/A
- Revenue
- KRMD $35,083,740.00
- SEER $14,170,000.00
- Revenue This Year
- KRMD $16.50
- SEER $23.54
- Revenue Next Year
- KRMD $15.47
- SEER $42.98
- P/E Ratio
- KRMD N/A
- SEER N/A
- Revenue Growth
- KRMD 19.65
- SEER N/A
- 52 Week Low
- KRMD $1.86
- SEER $1.56
- 52 Week High
- KRMD $5.05
- SEER $2.63
- Technical
- Relative Strength Index (RSI)
- KRMD 64.92
- SEER 41.77
- Support Level
- KRMD $2.51
- SEER $1.88
- Resistance Level
- KRMD $3.35
- SEER $1.97
- Average True Range (ATR)
- KRMD 0.19
- SEER 0.10
- MACD
- KRMD 0.09
- SEER -0.02
- Stochastic Oscillator
- KRMD 81.31
- SEER 0.00
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.